MNKD Long Put Strategy

MNKD (MannKind Corporation), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.

MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocrinologists, and other healthcare providers for the treatment of hypothyroidism. The company has a license and collaboration agreement with United Therapeutics Corporation. It also has an agreement with NRx Pharmaceuticals to develop a dry powder formulation of ZYESAMI (aviptadil), a synthetic form of human vasoactive intestinal peptide to help protect cells against inflammatory conditions. MannKind Corporation was incorporated in 1991 and is headquartered in Westlake Village, California.

MNKD (MannKind Corporation) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $991.7M, a beta of 1.04 versus the broader market, a 52-week range of 2.23-6.51, average daily share volume of 6.8M, a public-listing history dating back to 2004, approximately 403 full-time employees. These structural characteristics shape how MNKD stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.

A beta of 1.04 places MNKD roughly in line with broader market moves, so the strategy payoff and realized volatility track the index-equivalent baseline.

What is a long put on MNKD?

A long put buys downside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes below the strike minus premium at expiration.

Current MNKD snapshot

As of May 15, 2026, spot at $3.08, ATM IV 91.01%, IV rank 14.43%, expected move 26.09%. The long put on MNKD below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 28-day expiry.

Why this long put structure on MNKD specifically: MNKD IV at 91.01% is on the cheap side of its 1-year range, which favors premium-buying structures like a MNKD long put, with a market-implied 1-standard-deviation move of approximately 26.09% (roughly $0.80 on the underlying). The 28-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated MNKD expiries trade a higher absolute premium for lower per-day decay. Position sizing on MNKD should anchor to the underlying notional of $3.08 per share and to the trader's directional view on MNKD stock.

MNKD long put setup

The MNKD long put below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With MNKD near $3.08, the first option leg uses a $3.08 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed MNKD chain at a 28-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 MNKD shares for the stock leg in covered calls and collars).

ActionTypeStrike / BasisPremium (est)
Buy 1Put$3.08N/A

MNKD long put risk and reward

Net Premium / Debit
N/A
Max Profit (per contract)
Unbounded
Max Loss (per contract)
Unbounded
Breakeven(s)
None on modeled curve
Risk / Reward Ratio
N/A

Max profit equals the strike minus premium times 100 (reached at zero); max loss equals the premium times 100. Breakeven is strike minus premium.

MNKD long put payoff curve

Modeled P&L at expiration across a range of underlying prices for the long put on MNKD. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.

When traders use long put on MNKD

Long puts on MNKD hedge an existing long MNKD stock position or express a bearish view with defined risk; position sizing typically scales the put notional to the underlying MNKD exposure being hedged.

MNKD thesis for this long put

The market-implied 1-standard-deviation range for MNKD extends from approximately $2.28 on the downside to $3.88 on the upside. A MNKD long put expresses a directional view that the underlying closes below the strike minus premium at expiration, frequently sized to hedge an existing long MNKD position with one put per 100 shares held. Current MNKD IV rank near 14.43% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on MNKD at 91.01%. As a Healthcare name, MNKD options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to MNKD-specific events.

MNKD long put positions are structurally bearish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. MNKD positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move MNKD alongside the broader basket even when MNKD-specific fundamentals are unchanged. Long-premium structures like a long put on MNKD are particularly exposed to IV-crush risk through scheduled events (earnings, FDA decisions, central-bank meetings) where IV typically contracts post-event regardless of the directional outcome. Always rebuild the position from current MNKD chain quotes before placing a trade.

Frequently asked questions

What is a long put on MNKD?
A long put on MNKD is the long put strategy applied to MNKD (stock). The strategy is structurally bearish: A long put buys downside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes below the strike minus premium at expiration. With MNKD stock trading near $3.08, the strikes shown on this page are snapped to the nearest listed MNKD chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
How are MNKD long put max profit and max loss calculated?
Max profit equals the strike minus premium times 100 (reached at zero); max loss equals the premium times 100. Breakeven is strike minus premium. For the MNKD long put priced from the end-of-day chain at a 30-day expiry (ATM IV 91.01%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
What is the breakeven for a MNKD long put?
The breakeven for the MNKD long put priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current MNKD market-implied 1-standard-deviation expected move is approximately 26.09%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
When should you consider a long put on MNKD?
Long puts on MNKD hedge an existing long MNKD stock position or express a bearish view with defined risk; position sizing typically scales the put notional to the underlying MNKD exposure being hedged.
How does current MNKD implied volatility affect this long put?
MNKD ATM IV is at 91.01% with IV rank near 14.43%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.

Related MNKD analysis